SCHEMBL15568556

SCHEMBL15568556

c1ccc(Cn2c(CN3CCNCC3)nc3ccccc32)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.78
▸ KMT2A Q03164 3/20 0.78
▸ CYP1A2 P05177 2/20 0.78
▸ CYP2D6 P10635 2/20 0.78
▸ CYP2C9 P11712 2/20 0.78
▸ CYP2C19 P33261 2/20 0.78
▸ ALDH1A1 P00352 1/20 0.78
▸ HTR3A P46098 1/20 0.66
▸ HIF1A Q16665 2/20 0.64
▸ TDP1 Q9NUW8 2/20 0.64
▸ LMNA P02545 2/20 0.64
▸ NR1I2 O75469 1/20 0.64
▸ ABCB11 O95342 1/20 0.64
▸ ESR1 P03372 1/20 0.64
▸ PGR P06401 1/20 0.64
▸ CYP3A4 P08684 1/20 0.64
▸ PKM P14618 1/20 0.64
▸ TSHR P16473 1/20 0.64
▸ ADRA2B P18089 1/20 0.64
▸ HTR2A P28223 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15568337 0.86 CYP1A2 (0.97) MEN1KMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL15568468 0.82 MEN1 (0.74) MEN1KMT2ACYP1A2CYP2D6CYP2C9
Lerisetron SCHEMBL141124 0.80 HTR3A (1.00) HTR3A
Lerisetron SCHEMBL30669539 0.80 HTR3A (1.00) HTR3A
SCHEMBL14602995 0.79 LMNA (0.67) MEN1KMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL9537283 0.79 KCNH2 (0.58) MEN1KMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL6585574 0.79 GRM2 (0.67) ALDH1A1LMNAMAPTNPSR1GRM2
SCHEMBL14603001 0.79 MEN1 (0.69) MEN1KMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL15568517 0.79 ALDH1A1 (0.69) MEN1KMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL13508637 0.78 CYP1A2 (0.82) MEN1KMT2ACYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 — — WO claimed
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 — — WO disclosed
Send feedback